Dr. Sarah Tamara Menacho, MD

Dr. Menacho practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Menacho's NPI, 1861645087, was assigned on October 31, 2008. Dr. Menacho graduated from University of Vermont College of Medicine in 2008. Dr. Menacho holds Texas license Q4955.

Dr. Menacho's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Menacho's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Menacho is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Department of Anesthesiology. Dmand AI also links Dr. Menacho to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Menacho practices, 5 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Menacho's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Menacho is licensed in Texas.

CMS data shows 255 Medicare services from Dr. Menacho across 10 procedure codes in 2024, for 142 Medicare patients. Medicare paid $57,661 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 142 Medicare patients who saw Dr. Menacho in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Menacho's median patient age at 70, with 52% women.

In 2024, Dr. Menacho wrote 47 Medicare Part D claims for 15 patients. 100% of them were for generic drugs. CMS names the drug for 26 of them, across 1 drug with 11 or more claims each, at $267 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Menacho for performance year 2024, reported as part of a group. Dr. Menacho accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Menacho as offering telehealth.

Dmand AI links 46 papers to Dr. Menacho, published from 2018 to 2025. 2019 was the busiest year, with 8. The most frequent topics are Brain Injuries, Traumatic, Brain Neoplasms and Postoperative Complications. Dr. Menacho has published most often in World Neurosurg. Dr. Menacho's most frequent co-authors are Ramesh Grandhi, MD, Michael Karsy, MD and William Tupper Couldwell, MD.

CMS Open Payments shows 5 general payments to Dr. Menacho from 3 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $173.

Dr. Menacho graduated from University of Vermont College of Medicine in 2008.